Paul A Tambyah

Paul A Tambyah

National University of Singapore

H-index: 75

Asia-Singapore

About Paul A Tambyah

Paul A Tambyah, With an exceptional h-index of 75 and a recent h-index of 56 (since 2020), a distinguished researcher at National University of Singapore, specializes in the field of Device associated infections, Emerging infectious diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Study protocol: infectious diseases consortium (I3D) for study on integrated and innovative approaches for management of respiratory infections: respiratory infections research …

Elevated serum lactate dehydrogenase aids prediction of mortality in Pneumocystis jirovecii pneumonia without underlying human immunodeficiency virus infection–derivation of a …

Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised …

Biomarkers of early SARS-CoV-2 infection before the onset of respiratory symptoms

The role of an artificial intelligence model in antiretroviral therapy counselling and advice for people living with HIV

A Dermatomal Rash: Challenge

Jarisch–Herxheimer reaction in a patient with Weil’s disease

A Dermatomal Rash: Answer

Paul A Tambyah Information

University

Position

___

Citations(all)

23919

Citations(since 2020)

13994

Cited By

14983

hIndex(all)

75

hIndex(since 2020)

56

i10Index(all)

274

i10Index(since 2020)

178

Email

University Profile Page

National University of Singapore

Google Scholar

View Google Scholar Profile

Paul A Tambyah Skills & Research Interests

Device associated infections

Emerging infectious diseases

Top articles of Paul A Tambyah

Title

Journal

Author(s)

Publication Date

Study protocol: infectious diseases consortium (I3D) for study on integrated and innovative approaches for management of respiratory infections: respiratory infections research …

BMC Infectious Diseases

Dorothy Hui Lin Ng

Travis Ren Teen Chia

Barnaby Edward Young

Sapna Sadarangani

Ser Hon Puah

...

2024/1/23

Elevated serum lactate dehydrogenase aids prediction of mortality in Pneumocystis jirovecii pneumonia without underlying human immunodeficiency virus infection–derivation of a …

Journal of Infection and Public Health

Matthew Chung Yi Koh

Jinghao Nicholas Ngiam

Paul Anantharajah Tambyah

Lionel Hon-Wai Lum

2024/4/26

Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised …

The Lancet Respiratory Medicine

Yin Mo

Suchart Booraphun

Andrew Yunkai Li

Pornanan Domthong

Gyan Kayastha

...

2024/1/22

Biomarkers of early SARS-CoV-2 infection before the onset of respiratory symptoms

Clinical Microbiology and Infection

Ooiean Teng

Amy May Lin Quek

Tuong Minh Nguyen

Suqing Wang

Isabel Xue Qi Ng

...

2023/12/29

The role of an artificial intelligence model in antiretroviral therapy counselling and advice for people living with HIV

HIV medicine

Matthew Chung Yi Koh

Jinghao Nicholas Ngiam

Joy Yong

Paul Anantharajah Tambyah

Sophia Archuleta

2024/1/2

A Dermatomal Rash: Challenge

The American Journal of Dermatopathology

Matthew Chung Yi Koh

Paul Anantharajah Tambyah

MeiQi May Liau

Soon Boon Justin Wong

Kong-Bing Tan

2024/3/1

Jarisch–Herxheimer reaction in a patient with Weil’s disease

Singapore Medical Journal

Jinghao Nicholas Ngiam

Tiara Joy Foo

Genevieve MY Tan

Jason Phua

Hui Fang Lim

...

2024/1/2

A Dermatomal Rash: Answer

The American Journal of Dermatopathology

Matthew Chung Yi Koh

Paul Anantharajah Tambyah

MeiQi May Liau

Soon Boon Justin Wong

Kong-Bing Tan

2024/3/1

Artificial intelligence models for pre-travel consultation and advice: yea or nay?

Journal of Travel Medicine

Jinghao Nicholas Ngiam

Matthew Chung Yi Koh

Priscillia Lye

Tze Sian Liong

Brenda Mae Alferez Salada

...

2024/1

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

EClinicalMedicine

Ilias I Siempos

Andre C Kalil

Drifa Belhadi

Viviane Cordeiro Veiga

Alexandre Biasi Cavalcanti

...

2024/3/1

Heterogenous antibody and T‐cell responses to SARS‐CoV‐2 mRNA vaccines among immunocompromised young people

Clinical and Translational Medicine

Liangjian Lu

Chang Yien Chan

Pauline PL Chan‐Ng

Mya Than

Pamela SY Tan

...

2023/1

Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study

The Lancet Microbe

Jinnethe Reyes

Lauren Komarow

Liang Chen

Lizhao Ge

Blake M Hanson

...

2023/3/1

Antibiotic treatment failure of uncomplicated urinary tract infections in primary care

Antimicrobial Resistance & Infection Control

Sky Wei Chee Koh

Tracy Si Min Ng

Victor Weng Keong Loh

Jun Cong Goh

Si Hui Low

...

2023/8/1

Clinical Course, Immunogenicity, and Efficacy of BNT162b2 mRNA Vaccination Against SARS-CoV-2 Infection in Liver Transplant Recipients

Transplantation Direct

Eunice X Tan

Wen Hui Lim

Elizabeth Thong

Jean-Marc Chavatte

Jinyan Zhang

...

2023/10/1

Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2

Scientific Reports

Yue Gu

Bhuvaneshwari Shunmuganathan

Xinlei Qian

Rashi Gupta

Rebecca SW Tan

...

2023/12/9

Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies

The Journal of Infection

Lydia Su Yin Wong

Evelyn Xiu Ling Loo

Chiung-Hui Huang

Gaik Chin Yap

Michelle Jia Yu Tay

...

2023/1

Sub genomic analysis of SARS-CoV-2 using short read amplicon-based sequencing

Frontiers in genetics

Lian Chye Winston Koh

Yiqi Seow

Kiat Whye Kong

Chun Kiat Lee

Benedict Yan

...

2023/2/24

Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?

Jinghao Nicholas Ngiam

Abdurrahmaan Al-Mubaarak

Sebastian Maurer-Stroh

Paul Anantharajah Tambyah

2023/6/26

Neutralization escape of emerging subvariants XBB. 1.5/1.9. 1 and XBB. 2.3 from current therapeutic monoclonal antibodies

Journal of medical virology

Charmaine WY Chew

He Ping Yeo

Paul A Tambyah

Barnaby E Young

Gladys GY Tan

...

2023/9

414. Sex differences in clinical presentation and outcomes amongst hospitalized patients with COVID-19 in Singapore

Open Forum Infectious Diseases

Matthew CY Koh

Jinghao Nicholas Ngiam

Srishti Chhabra

Wilson Goh

Meng Ying Sim

...

2023/12

See List of Professors in Paul A Tambyah University(National University of Singapore)